InvestorsHub Logo
Followers 13
Posts 5885
Boards Moderated 0
Alias Born 10/07/2017

Re: Smartypants2 post# 23653

Wednesday, 05/03/2023 6:44:50 PM

Wednesday, May 03, 2023 6:44:50 PM

Post# of 33009
MORE LAME BS
That was NEVER what the MovyChem/XERI JV was created for. Filing shows MovyChem's obligation was to supply the patents only for Retacelas as stated in the 8-K. Just BS saying MC was to supply XERI's Nexboard.

For its capital contribution to the Joint Venture, pursuant to a Patent and Exclusive License and Assignment Agreement (the “Patent Agreement”), Movychem is transferring to the Joint Venture all of its interest to the know-how and intellectual property relating to Retacell exclusive of all patents, and the Company is contributing the amount of $2,600,000 payable (a) $600,000 at the rate of $25,000 per month over a 24 month period and (b) $2,000,000 within five business days of a closing of a financing in which the Company receives net proceeds of at least $3,000,000 but in no event later than six months from the Effective Date. At such time as the Company makes its $2,000,000 payment (and assuming the Company is current with its then monthly capital contributions), pursuant to the Patent Agreement, Movychem will transfer all of its rights, title and interest to all of the patents related to Retacell for an amount equal to aggregate cash contributions of the Company to the Joint Venture plus 40% of all royalty payments received by the Joint Venture for the licensing of Retacell products. Pending assignment of the patents to the Joint Venture, pursuant to the Patent Agreement, Movychem has granted to the Joint Venture an exclusive worldwide license under the patents.

TIC TOC
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XERI News